Pipeline shield with single antiplatelet therapy in aneurysmal subarachnoid haemorrhage: multicentre experience

BACKGROUND: The Pipeline Embolisation Device with Shield technology (PED-Shield) is suggested to have reduced thrombogenicity. This reduced thrombogenicity may make it possible to use safely in the acute treatment of aneurysmal subarachnoid haemorrhage (aSAH) on single antiplatelet therapy (SAPT). O...

Descripción completa

Detalles Bibliográficos
Autores principales: Manning, Nathan W, Cheung, Andrew, Phillips, Timothy J, Wenderoth, Jason D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Hemorrhagic Stroke
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582735/
https://www.ncbi.nlm.nih.gov/pubmed/30552166
http://dx.doi.org/10.1136/neurintsurg-2018-014363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582735/
https://www.ncbi.nlm.nih.gov/pubmed/30552166
http://dx.doi.org/10.1136/neurintsurg-2018-014363

Ejemplares similares